Biora Therapeutics

BIOR

Q3 FY2024 Earnings

Financial report interval: 2024.06.30 - 2024.09.30

Overview: Biora Therapeutics(BIOR) the Revenue is 32 K (--%);the EPS is -5.04 (+89.7%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EPS
-5.037789.70%
----
----

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly